Company
Autolus Therapeutics
Autolus - developing CAR T cell therapies for patients with cancer and autoimmune diseases
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Autolus is a commercial-stage CAR T-cell therapy company, applying its extensive programming capabilities to develop advanced autologous T-cell therapies that have the potential to deliver life-changing treatments to patients with cancer and autoimmune diseases
Loading relationship preview